Institutional investors hold a majority ownership of LLY through the 66.08% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2017, these large investors purchased a net $9.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 3.4 Million shares of Eli Lilly and Co
BESSEMER INVESTMENT MANAGEMENT L... Bought 3.1 Million shares of Eli Lilly and Co
BEUTEL, GOODMAN & CO. LTD. Bought 2.3 Million shares of Eli Lilly and Co